Jun 24, 2024 05:58PM
Nov 6, 2023 02:44AM
Aug 2, 2023 08:17AM
Aug 2, 2023 08:17AM
Jul 17, 2023 04:07PM
Jul 17, 2023 04:05PM
Jul 12, 2023 08:03AM Aridis Pharmaceuticals (ARDS) AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
Jul 12, 2023 08:00AM
Jun 30, 2023 09:00AM
Jun 20, 2023 08:00AM
Jun 20, 2023 08:00AM
Jun 8, 2023 04:05PM
May 31, 2023 08:04AM
May 31, 2023 08:00AM Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design
May 25, 2023 04:05PM
Apr 26, 2023 12:15PM
Apr 26, 2023 12:15PM
Mar 31, 2023 07:00PM
Mar 14, 2023 09:45AM
Mar 14, 2023 09:45AM
Mar 13, 2023 08:01AM Aridis Pharmaceuticals (ARDS) Reports AR-501 Met Primary and Secondary Endpoints in Phase 2a Study
Mar 13, 2023 08:00AM
Feb 17, 2023 08:00AM
Jan 25, 2023 04:28PM
Jan 25, 2023 04:05PM
Jan 17, 2023 04:30PM
Dec 28, 2022 08:30AM
Dec 12, 2022 08:05AM (Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
Dec 12, 2022 08:05AM
Dec 12, 2022 07:06AM
Dec 12, 2022 07:00AM
Dec 12, 2022 07:00AM
Dec 5, 2022 07:00AM
Dec 5, 2022 07:00AM
Nov 30, 2022 07:00AM Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients
Nov 30, 2022 07:00AM
Nov 22, 2022 09:10AM
Nov 22, 2022 09:10AM
Nov 21, 2022 06:30PM
Nov 21, 2022 06:30PM
Oct 4, 2022 08:00AM
Sep 27, 2022 09:20AM Aridis Pharmaceuticals (ARDS) Withdraws Proposed Stock Offering
Sep 27, 2022 09:20AM
Sep 26, 2022 03:38PM
Sep 26, 2022 03:37PM
Aug 16, 2022 04:15PM
Aug 10, 2022 08:31AM
Aug 10, 2022 08:30AM
Jun 30, 2022 09:00AM RedChip Interviews Aridis Pharmaceuticals' CEO Vu Truong
Jun 3, 2022 08:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All